- Home
- PROK vs EAF Comparison
PROK vs EAF Comparison
Compare PROK & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROK | EAF |
|---|---|---|
| Founded | 2015 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.4M | 320.1M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PROK | EAF |
|---|---|---|
| Price | $0.91 | $11.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $6.50 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 1.1M | 598.9K |
| Earning Date | 11-13-2026 | 10-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $893,000.00 | ★ $504,134,000.00 |
| Revenue This Year | N/A | $2.85 |
| Revenue Next Year | N/A | $20.35 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1075.00 | N/A |
| 52 Week Low | $1.29 | $4.92 |
| 52 Week High | $2.95 | $19.72 |
Technical Indicators
Market Signals| Indicator | PROK | EAF |
|---|---|---|
| Relative Strength Index (RSI) | 25.21 | 66.24 |
| Support Level | N/A | $5.79 |
| Resistance Level | $2.01 | $19.72 |
| Average True Range (ATR) | 0.14 | 0.92 |
| MACD | -0.03 | 0.43 |
| Stochastic Oscillator | 5.16 | 82.47 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products used as raw material in the production of graphite electrodes.